Phathom Pharmaceuticals Inc

NASDAQ:PHAT   4:00:00 PM EDT
10.95
-0.12 (-1.08%)
4:01:59 PM EDT: $10.95 0.00 (0.00%)
Earnings Announcements

Phathom Pharmaceuticals Reports Q3 2022 Results

Published: 11/08/2022 23:25 GMT
Phathom Pharmaceuticals Inc (PHAT) - Phathom Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updates.
Qtrly Net Loss per Share $1.32.
Q4 Earnings per Share View $-1.32 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.35

Next Quarter Revenue Guidance is expected to be $1.66 Million
Next Quarter EPS Guidance is expected to be -$1.54

More details on our Analysts Page.